Renub

    Japan Proton Therapy Market, Share, Forecast 2024-2030, Industry Trends, Growth, Size, Companies Analysis

    Excel: 12 Hours
    PDF: 24 Hours
    Jan 2022
    Pages: 130

    Japan Proton Therapy Market Outlook

    Japan Proton Therapy Market Potential will be US$ 8.6 Billion by 2027. Over the years, various techniques for cancer treatment have emerged, such as chemotherapy, surgery, and proton therapy. The proton therapy is the new technology and is expected to least impair the quality of life compared to other forms of treatment. Japan has one of the highest numbers of proton therapy treatment clinics globally. The improving cutting-edge technology in radiotherapy and growing technological development in Japan will further drive the Japan proton therapy industry in the future.


    COVID-19 Impact on Japan Proton Therapy Industry

    Despite the outbreak of COVID-19 worldwide, the proton therapy market has grown at a constant rate. Proton therapy’s radiation therapy was stopped for a brief round period, but it was resumed for patients. In addition, to take care of the regular patient and radiation therapies patients in Japan, many processes have been finalized to help the patients with therapies; as such many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.

     

    japan proton therapy market


    Japan Proton Therapy Potential Market Size was US$ 6.1 Billion post-pandemic recoveries in 2021

    The growth of the proton therapy market in Japan is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation, and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access and premium pricing. As these systems become more widespread, they are likely to require further refinement and enhancement to respond to the needs of medical staff.


    Cancer Types - Market Segmentation

    Based on Cancer Types, the proton therapy market of Japan is further segmented into Central Nervous System (CNS) Tumors, Head and Neck Cancer, Lung Cancer, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC) Cancer, Pancreas Cancer, Gynecologic Cancers, Prostate Cancer, Bone, and Soft Tissue Cancer and Other Cancer. According to Renub Research report, Japan Proton Therapy Industry is expected to grow with a CAGR of 5.9% during 2021-2027.


    Besides, proton therapy applications are more inclined towards Gastrointestinal Tract Cancer and lung cancer due to references by healthcare specialists. Moreover, proton therapy is also recognized to be comparatively safer in the case of patients with central nervous system (CNS) tumors.


    Although there is less experience with proton therapy combined with chemotherapy for pancreatic cancer, favorable outcomes have been reported recently in Japan. Remarkably, these applications are anticipated to drive the revenue for the proton therapy industry over the forecast period.


    Competitive Landscape

    Companies existing in the Japan Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich its product catalogs through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players of the Japan Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.


    Renub Research report "Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others), Companies (IBA Proton Therapy, Varian Medical Systems, Elekta)" Reimbursement Policies & Persons Treated at Centers provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.

     

    japan proton therapy industry size


    Cancer Types – Japan Proton Therapy Number of Patients have been covered from 10 viewpoints:

    1.    Central Nervous System (CNS) Tumors
    2.    Head and Neck Cancer
    3.    Lung Cancer
    4.    GI (Gastro-Intestinal) Cancer
    5.    Hepatocellular Carcinoma (HCC) Cancer
    6.    Pancreas Cancer
    7.    Gynecologic Cancers
    8.    Prostate Cancer
    9.    Bone and Soft Tissue Cancer
    10.    Others Cancer


    Cancer Types – Japan Proton Therapy Market have been covered from 10 viewpoints:

    1.    Central Nervous System (CNS) Tumors
    2.    Head and Neck Cancer
    3.    Lung Cancer
    4.    GI (Gastro-Intestinal) Cancer
    5.    Hepatocellular Carcinoma (HCC) Cancer
    6.    Pancreas Cancer
    7.    Gynecologic Cancers
    8.    Prostate Cancer
    9.    Bone and Soft Tissue Cancer
    10.    Others Cancer


    All companies have been covered from 3 viewpoints:

    •    Overview
    •    Recent Developments
    •    Sales Analysis


    Companies Covered:

    1.    IBA Proton Therapy
    2.    Varian Medical Systems
    3.    Elekta


    Report Details:

    Report Features Details
    Base Year 2021
    Historical Period 2016 - 2021
    Forecast Period 2022-2027
    Market US$ Billion
    Segment Covered Cancer Types
    Companies Covered IBA Proton Therapy, Varian Medical Systems, Elekta
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

     

    Frequently Asked Questions:

    • What are the growth estimates for Japan proton therapy market till 2027?
    • Which are the prominent proton therapy market players across Japan?
    • What are the key factors hampering growth of the proton therapy market in the Japan?
    • What are the key factors driving growth of the Japanproton therapy market?
    • What are the Japan proton therapy market trends?
    • Which are the major companies operating in the Japanproton therapy market landscape?
    • How did the ongoing coronavirus (COVID-19) pandemic impact Japanproton therapy industry growth?

    1.    Introduction

    2.    Research & Methodology
    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Japan Proton Therapy Market (Actual & Untapped)

    5.1    Actual Proton Therapy Market
    5.2    Untapped Proton Therapy Market


    6.    Number of Patients – Japan Proton Therapy

    6.1    Actual Numbers
    6.2    Untapped Numbers


    7.    Cancer Types – Japan Proton Therapy Number of Patients

    7.1    Central Nervous System (CNS) Tumors
    7.2    Head and Neck Cancer
    7.3    Lung Cancer
    7.4    GI (Gastro-Intestinal) Cancer
    7.5    Hepatocellular Carcinoma (HCC) Cancer
    7.6    Pancreas Cancer
    7.7    Gynecologic Cancers
    7.8    Prostate Cancer
    7.9    Bone and Soft Tissue Cancer
    7.10    Others Cancer


    8.    Cancer Types – Japan Proton Therapy Market

    8.1    Central Nervous System (CNS) Tumors
    8.2    Head and Neck Cancer
    8.3    Lung Cancer
    8.4    GI (Gastro-Intestinal) Cancer
    8.5    Hepatocellular Carcinoma (HCC) Cancer
    8.6    Pancreas Cancer
    8.7    Gynecologic Cancers
    8.8    Prostate Cancer
    8.9    Bone and Soft Tissue Cancer
    8.10    Others Cancer


    9.    Japan – List of Proton Therapy Centers

    9.1    Operating Proton Therapy Centers
    9.2    Under-Construction Therapy Centers


    10.    Reimbursement Policies – Japan Proton Therapy

    11.    Components of a Standard Proton Therapy Center

    11.1    Type of Proton Accelerator

    11.1.1    Synchrotrons (example: LLUMC at Loma Linda)
    11.1.2    Cyclotrons (example: MGH Boston)
    11.1.3    Synchrocyclotrons (examples: Orsay, Uppsala)
    11.1.4    Linacs (Rome)
    11.1.5    H-minus Synchrotrons
    11.1.6    Separated Sector Cyclotrons
    11.1.7    Super-conducting Cyclotrons
    11.1.8    Fast Cycling Synchrotron

    11.2    Beam Transport System

    11.3    Beam Delivery System

    11.3.1    The Passive Scattering Technique
    11.3.2    Beam Scanning

    11.4    Type of Nozzle

    11.4.1    Single Scattering
    11.4.2    Double Scattering
    11.4.3    Uniform Scanning Nozzle
    11.4.4    Pencil Scanning Nozzle

    11.5    Treatment Planning System
    11.6    Image Viewers
    11.7    Patient Positioning System (PPS)
    11.8    Human Resource


    12.    Porters Five Forces

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes


    13.    Company Analysis

    13.1    IBA Proton Therapy

    13.1.1    Overview
    13.1.2    Recent Development
    13.1.3    Sales Analysis

    13.2    Varian Medical Systems

    13.2.1    Overview
    13.2.2    Recent Development
    13.2.3    Sales Analysis

    13.3    Elekta

    13.3.1    Overview
    13.3.2    Recent Development
    13.3.3    Sales Analysis


    List Of Figures:

    Figure-01:        Japan – Actual Proton Therapy Market (Million US$), 2016 – 2021
    Figure-02:        Japan – Forecast for Actual Proton Therapy Market (Million US$), 2022 – 2027
    Figure-03:        Japan – Untapped Proton Therapy Market (Million US$), 2016 – 2021
    Figure-04:        Japan – Forecast for Untapped Proton Therapy Market (Million US$), 2022 – 2027
    Figure-05:        Japan – Actual Numbers (Number), 2016 – 2021
    Figure-06:        Japan – Forecast for Actual Numbers (Number), 2022 – 2027
    Figure-07:        Japan – Untapped Numbers (Number), 2016 – 2021
    Figure-08:        Japan – Forecast for Untapped Numbers (Number), 2022 – 2027
    Figure-09:        Japan – Central Nervous System (CNS) Tumors Patients (Number), 2016 – 2021
    Figure-10:        Japan – Forecast for Central Nervous System (CNS) Tumors Patients (Number), 2022 – 2027
    Figure-11:        Japan – Head and Neck Cancer Patients (Number), 2016 – 2021
    Figure-12:        Japan – Forecast for Head and Neck Cancer Patients (Number), 2022 – 2027
    Figure-13:        Japan – Lung Cancer Patients (Number), 2016 – 2021
    Figure-14:        Japan – Forecast for Lung Cancer Patients (Number), 2022 – 2027
    Figure-15:        Japan – GI (Gastro-Intestinal) Cancer Patients (Number), 2016 – 2021
    Figure-16:        Japan – Forecast for GI (Gastro-Intestinal) Cancer Patients (Number), 2022 – 2027
    Figure-17:        Japan – Hepatocellular Carcinoma (HCC) Cancer Patients (Number), 2016 – 2021
    Figure-18:        Japan – Forecast for Hepatocellular Carcinoma (HCC) Cancer Patients (Number), 2022 – 2027
    Figure-19:        Japan – Pancreas Cancer Patients (Number), 2016 – 2021
    Figure-20:        Japan – Forecast for Pancreas Cancer Patients (Number), 2022 – 2027
    Figure-21:        Japan – Gynecologic Cancers Patients (Number), 2016 – 2021
    Figure-22:        Japan – Forecast for Gynecologic Cancers Patients (Number), 2022 – 2027
    Figure-23:        Japan – Prostate Cancer Patients (Number), 2016 – 2021
    Figure-24:        Japan – Forecast for Prostate Cancer Patients (Number), 2022 – 2027
    Figure-25:        Japan – Bone and Soft Tissue Cancer Patients (Number), 2016 – 2021
    Figure-26:        Japan – Forecast for Bone and Soft Tissue Cancer Patients (Number), 2022 – 2027
    Figure-27:        Japan – Others Cancer Patients (Number), 2016 – 2021
    Figure-28:        Japan – Forecast for Others Cancer Patients (Number), 2022 – 2027
    Figure-29:        Japan – Central Nervous System (CNS) Tumors Market (Million US$), 2016 – 2021
    Figure-30:        Japan – Forecast for Central Nervous System (CNS) Tumors Market (Million US$), 2022 – 2027
    Figure-31:        Japan – Head and Neck Cancer Market (Million US$), 2016 – 2021
    Figure-32:        Japan – Forecast for Head and Neck Cancer Market (Million US$), 2022 – 2027
    Figure-33:        Japan – Lung Cancer Market (Million US$), 2016 – 2021
    Figure-34:        Japan – Forecast for Lung Cancer Market (Million US$), 2022 – 2027
    Figure-35:        Japan – GI (Gastro-Intestinal) Cancer Market (Million US$), 2016 – 2021
    Figure-36:        Japan – Forecast for GI (Gastro-Intestinal) Cancer Market (Million US$), 2022 – 2027
    Figure-37:        Japan – Hepatocellular Carcinoma (HCC) Cancer Market (Million US$), 2016 – 2021
    Figure-38:        Japan – Forecast for Hepatocellular Carcinoma (HCC) Cancer Market (Million US$), 2022 – 2027
    Figure-39:        Japan – Pancreas Cancer Market (Million US$), 2016 – 2021
    Figure-40:        Japan – Forecast for Pancreas Cancer Market (Million US$), 2022 – 2027
    Figure-41:        Japan – Gynecologic Cancers Market (Million US$), 2016 – 2021
    Figure-42:        Japan – Forecast for Gynecologic Cancers Market (Million US$), 2022 – 2027
    Figure-43:        Japan – Prostate Cancer Market (Million US$), 2016 – 2021
    Figure-44:        Japan – Forecast for Prostate Cancer Market (Million US$), 2022 – 2027
    Figure-45:        Japan – Bone and Soft Tissue Cancer Market (Million US$), 2016 – 2021
    Figure-46:        Japan – Forecast for Bone and Soft Tissue Cancer Market (Million US$), 2022 – 2027
    Figure-47:        Japan – Others Cancer Market (Million US$), 2016 – 2021
    Figure-48:        Japan – Forecast for Others Cancer Market (Million US$), 2022 – 2027
    Figure-49:        IBA Proton Therapy – Global Revenue (Million US$), 2016 – 2021
    Figure-50:        IBA Proton Therapy – Forecast for Global Revenue (Million US$), 2022 – 2027
    Figure-51:        Varian Medical Systems – Global Revenue (Million US$), 2016 – 2021
    Figure-52:        Varian Medical Systems – Forecast for Global Revenue (Million US$), 2022 – 2027
    Figure-53:        Elekta – Global Revenue (Million US$), 2016 – 2021
    Figure-54:        Elekta – Forecast for Global Revenue (Million US$), 2022 – 2027


    List Of Tables:

    Table-1:        Japan – Proton Therapy Centers in Operation
    Table-2:        Japan – Proton Therapy Centers in Under-Construction

    • Description
      Price
    • Chapter 1, 2, 3 & 4     Pages : 6
      $1,000
    • Chapter 5 & 6     Pages : 12
      $1,000
    • Chapter 7     Pages : 32
      $800
    • Chapter 8     Pages : 32
      $800
    • Chapter 9     Pages : 6
      $500
    • Chapter 10     Pages : 2
      $400
    • Chapter 11     Pages : 15
      $600
    • Chapter 12     Pages : 6
      $400
    • Chapter 13.1     Pages : 5
      $150
    • Chapter 13.2     Pages : 5
      $150
    • Chapter 13.3     Pages : 5
      $150

    Related Reports